GI CONNECT has identified the Management of Skin Toxicities from Multikinase Inhibitor Therapies (MKIs) on the ESMO OncologyPRO portal as a practical guide on how to prevent and treat skin toxicities from MKIs

 

Management of Skin Toxicities from Multi Kinase Inhibitors (MKIs)

Dr.Guillem Argilés (medical oncologist), Paz Fernández Ortega (clinical nurse specialist) and Prof. Siegfried Segaert (dermatologist) updated this helpful resource.  With almost 100,000 visits, healthcare professionals continue to value the practical guidance available.

This important resource aims to;

1) Explore the side effects of inhibiting receptor tyrosine kinases (RTK)

2) Provide expert advice on the prophylaxis and treatment of skin toxicities

3) Provide recommendation on how to manage side effects while maintaining treatment with MKIs

Primarily this guidance exists for healthcare professionals and contains information, treatment algorithms and educational materials relating to the management of dermatological side effects in patients treated with MKIs.

However, there is also a helpful section for patients and caregivers on skin, mouth and hair changes that can sometimes occur with this particular type of treatment. 

COR2ED have donated this content to ESMO to ensure that the practical guide reflects today's best clinical practice in managing skin toxicities from MKIs.

Dr Guillem Argilés obtained his medical degree at the Vall d’Hebron University Hospital in Barcelona, Spain. He later obtained his M.D., supervised by José Baselga M.D., in 2006 at the same institute. In 2010, he joined the Gastrointestinal Malignancies Division led by Josep Tabernero M.D., Ph.D. Dr Argilés currently works in the Gastrointestinal Malignancies and Developmental Therapeutics Divisions of the same institute, where his research is focused on chemorefractory colorectal cancer, personalized medicine, as well as the molecular biology of colorectal cancer.

Paz Fernández is the Nursing Research Coordinator at the Catalan Institute of Oncology in Barcelona and since 2010, Associated Professor at the Faculty of Medicine and Health Sciences at the University of Barcelona, where she earned her Doctorate in Nursing Sciences and a Bachelor in Clinical Psychology. From 1999 to 2005, Paz has been a member on the Executive Board of EONS (European Oncology Nursing Society), and until 2001, a Board member of SEEO (Spanish Oncology Nursing Society). Paz belongs to the Node of Cancer at Joanna Briggs Institute and to the EANS (European Academy of Nursing Science) scholars group. Her area of expertise is symptoms management in cancer patients, chemoterapy and oral anticancer drugs. In 2014 she received the EONS Lifetime Achievement Award for her 30 years in oncology and professional contribution to the field of oncology nursing.

Programme summary
  • clock Duration 30 MIN
  • clock Language(s) flag
Visit resource on ESMO OncologyPRO
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI CONNECT

GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre Laboratories.  

Meet the experts
Brought to you by
DERMATOLOGY CONNECT

DERMATOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grant from Glenmark Pharmaceuticals, Bayer and Pierre Fabre Laboratories.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update
Oncology 
ER+ metastatic breast cancer: Highlights from the 13th APBCS Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer  

Experts
Prof. Shaheenah Dawood, Prof. Heather McArthur, Prof. Javier Cortés, Prof. Frédérique Penault-Llorca
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Feb 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Σειρά podcast για τη διαχείριση της θρόμβωσης

Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast

Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Feb 2025

This educational programme is supported by an Independent Educational Grant from Viatris.
conference-update Conference update
Oncology 
ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial

How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?

Experts
Prof. François-Clément Bidard, Dr Barbara Pistilli
  • clock 5 MIN
  • calendar Feb 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast
Oncology Obstetrics and Gynecology 
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

Understanding the role of molecular subtypes in guiding treatment selection

Experts
Prof. Xavier Matias-Guiu, Dr Jurjees Hasan
Endorsed by
Biomarker Collaborative ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 11 MIN
  • calendar Feb 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this Video Podcast.
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Postępowanie w przypadku zakrzepicy – seria podcastów

Uznani eksperci dzielą się swoimi spostrzeżeniami. Kliknij na odpowiednią zakładkę, aby wybrać odcinek podcastu.

Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Feb 2025

This educational programme is supported by an Independent Educational Grant from Viatris.
conference-update Conference update
Oncology 
Highlights from ASCO GI 2025

Expert insights on BRAF-mutated colorectal cancer

Experts
Dr Elena Élez
Endorsed by
DiCE BRAF Bombers ICAN international cancer advocacy network
Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Feb 2025

Educational programme supported by an Independent Educational Grant from Pierre Fabre Laboratories. The programme is therefore independent, the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts. This content is intended for HCPs outside the UK and ROl only.